Avandia, the GlaxoSmithKline oral antidiabetic drug rosiglitazone maleate used to treat type II diabetes increases the risk of certain cardiovascular events according to recent studies. According to data reported to the FDA, adverse events of heart failure in patients using Avandia has been reported on since 2002 and now totals over 415 events. A New England Journal of Medicine study released in May 2007 showed a 43 percent increase in heart attacks in people using Avandia.
If you or a loved one has had a heart attack or other cardiovascular event after taking Avandia then you should call us toll free now at 1-866-374-0338 because you may be entitled to medical monitoring and compensation from the manufacturer.
From: http://ping.fm/I9jc5
